Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-465

5 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 51655-465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Atorvastatin-st (Atorvastatin St)
Chemical structure of Atorvastatin Calcium, showing the molecular arrangement including aromatic rings, hydroxyl groups, and calcium ions with hydration.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
A cumulative incidence curve chart comparing Atorvastatin and placebo groups over 3.5 years. The x-axis shows time in years, and the y-axis shows cumulative incidence percentage. The Atorvastatin group has a lower cumulative incidence than placebo, indicated by solid and dashed lines respectively. Hazard ratio and p-value are also noted.*
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
A cumulative hazard curve comparing Atorvastatin and Placebo over a 4 to 5 year follow-up period. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. Two lines display outcomes for Atorvastatin (solid line) and Placebo (dashed line), with a hazard ratio of 0.63 (95% CI: 0.48-0.83) and p=0.001 indicated on the graph.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
A line chart comparing subjects (%) experiencing the first major cardiovascular event over five years for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event. The chart includes a hazard ratio (HR) of 0.78 with a confidence interval (0.69-0.89) and a p-value of 0.0002.*
FDA Label Image

Label (51655 465 52 Rev B 07 22 Nhc)

Label (51655 465 52   Rev B 07 22 Nhc)
Label for Atorvastatin Calcium Tablets USP 40 mg, film-coated tablets by Northwind Health Company, LLC. The label indicates a bottle of 30 tablets for oral use, prescription only. Storage instructions specify controlled room temperature (20°-25°C). The NDC number 51655-465 is shown along with additional handling and packaging information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.